Medicare Enrolled

Dr. Anish Badjatiya, MD

Cardiovascular Disease · Sugar Land, TX
Low-engagement
16605 SOUTHWEST FWY, Sugar Land, TX 77479
3469012070
In practice since 2017 (9 years)
NPI: 1821520651 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Badjatiya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Badjatiya? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Badjatiya

Dr. Anish Badjatiya is a cardiovascular disease in Sugar Land, TX, with 9 years in practice.

Between the years covered by Open Payments, Dr. Badjatiya received a total of $13,842 from 23 pharmaceutical and/or device companies across 216 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Badjatiya is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice$ $13,842 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$13,842
Total received (2021-2024)
Avg $3,460/year across 4 years
Top 25% in TX for cardiovascular disease
23
Companies
216
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,331 (81.9%)
Scientific / Research
Research funding and grants
$2,402 (17.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$109 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,632
2023
$4,488
2022
$2,464
2021
$1,258

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$8,198
Boston Scientific Corporation
$2,207
Biosense Webster, Inc.
$1,195
PFIZER INC.
$475
AstraZeneca Pharmaceuticals LP
$300
Amgen Inc.
$279
E.R. Squibb & Sons, L.L.C.
$177
CARDIVA MEDICAL, INC.
$138
Esperion Therapeutics, Inc.
$125
SANOFI-AVENTIS U.S. LLC
$118
Medical Device Business Services, Inc.
$109
Cardiovascular Systems Inc.
$107
Saranas, Inc.
$88
BIOTRONIK INC.
$77
Astellas Pharma US Inc
$62
Actelion Pharmaceuticals US, Inc.
$34
BOSTON SCIENTIFIC CORPORATION
$31
Lexicon Pharmaceuticals, Inc.
$27
Bayer HealthCare Pharmaceuticals Inc.
$27
ShockWave Medical, Inc
$21
Contego Medical, Inc
$18
Janssen Pharmaceuticals, Inc
$16
Inari Medical, Inc.
$12
Top 3 companies account for 83.8% of total payments
Associated products mentioned in payments ›
ACCOLADE SR · ADAPTA · AFFERA MAPPING SYSTEM · AZURE XT DR MRI SURESCAN · BRILINTA · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · COBALT DR MRI SURESCAN · CareLink · Diamondback Coronary · ELIQUIS · FARXIGA · FLOWTRIEVER CATHETER · Inpefa · Kerendia · LEXISCAN · LUX-Dx Insertable Cardiac Monitor · MICRA · MULTAQ · NA · NEXLIZET · OCTARAY MAPPING CATHETER · OPSUMIT · PULSESELECT · RESOLUTE ONYX · RHYTHMIA · Repatha · Resolute · Rivacor · S · SELECTSECURE · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · VYNDAQEL · VenaSeal · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cardiovascular disease in Sugar Land?
Compare cardiovascular diseases in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
294
Per 100K population
34.2
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Badjatiya is a cardiovascular disease, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Badjatiya receive payments from pharmaceutical companies?
Yes. Dr. Badjatiya received a total of $13,842 from 23 companies across 216 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Badjatiya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →